tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and 2seventy bio (TSVT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sarepta Therapeutics (SRPTResearch Report) and 2seventy bio (TSVTResearch Report) with bullish sentiments.

Sarepta Therapeutics (SRPT)

SVB Securities analyst Joseph Schwartz reiterated a Buy rating on Sarepta Therapeutics today and set a price target of $160.00. The company’s shares closed last Friday at $128.56, close to its 52-week high of $134.08.

According to TipRanks.com, Schwartz has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -5.8% and a 41.2% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Mereo Biopharma Group Plc, and Ultragenyx Pharmaceutical.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Sarepta Therapeutics with a $149.27 average price target, which is a 16.3% upside from current levels. In a report issued on January 5, RBC Capital also maintained a Buy rating on the stock with a $204.00 price target.

See the top stocks recommended by analysts >>

2seventy bio (TSVT)

In a report released today, Salveen Richter from Goldman Sachs maintained a Buy rating on 2seventy bio, with a price target of $28.00. The company’s shares closed last Friday at $10.57, close to its 52-week low of $8.44.

According to TipRanks.com, Richter is a 5-star analyst with an average return of 26.7% and a 54.1% success rate. Richter covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Recursion Pharmaceuticals, and 4D Molecular Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for 2seventy bio with a $29.50 average price target, which is a 196.5% upside from current levels. In a report issued on January 5, SVB Securities also maintained a Buy rating on the stock with a $41.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SRPT:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles